Epitomics, Inc., an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research, diagnostic and therapeutic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays. Epitomics, Inc. (www.epitomics.com) is headquartered in Burlingame, California, and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.
Recently, Epitomics was issued two important industry-changing patents that go a long way towards solidifying the company’s position in the growing monoclonal antibody marketplace. To summarize the patents:
- Epitomics was issued patent no. 7,429,487, which covers the next generation of cells for producing rabbit monoclonal antibodies and further establishes Epitomics’ unique position as *the* rabbit monoclonal antibody company.
- Epitomics was issued patent no. 7,431,927 covering a broad grouping of anti-TNF (Tumor Necrosis Factor) antibodies. This potentially industry-changing antibody patent provides a sweeping grant of exclusivity that will broadly cover any antibody that contains the binding region of a particular rabbit TNF-neutralizing antibody, as well as a large number of variant antibodies that contain amino acid substitutions in the antibody’s binding region.
These are just two recent accomplishments – the founders of Epitomics have hundreds of antibody-related inventions to their credit and the company is continually innovating. Below are press releases detailing the two recent patents.
| Contact Details: |
| 863 Mitten Road Suite 103 |
| Burlingame |
| California |
| 94010-1303 |
| United States of America |
| Tel: | (650) 583-6688 |
| Fax: | (650) 583-6680 |
| Email: | info@epitomics.com |
| WWW: | www.epitomics.com/
|
|
Loading...
|
Press Releases on Epitomics, Inc.:
|
 |
| Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results |
19th May, 2009 |
Simcere Pharmaceutical Group |
NANJING, China, May 19 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group
("Simcere" or the "Company") (NYSE: SCR), a leading manufacturer and supplier
of branded generic and
|
| Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer |
16th December, 2008 |
Epitomics, Inc. |
BURLINGAME, Calif., Dec. 16 /PRNewswire/ -- Epitomics, Inc., the world's sole provider of humanized rabbit monoclonal antibodies for therapeutic use, today announced the appointment of Zhiqiang
|
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 790 times since April 2007, the link to the organisation's website has been followed 103 times
Recent Search Terms used to find this page: Epitomics.pdf | Epitomics Inc anti TNF monoclonal antibody | epitomics inc. | epitomics | epitomics inc | epitomics | Epitomics Inc. | epitomics | epitomics | epitomics | .
Search for more companies in Burlingame
Search for more companies in California
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Epitomics, Inc.
